Primary pure spindle cell carcinoma (sarcomatoid carcinoma) of the ovary: A case report with immunohistochemical study
© The Author(s). 2016
Received: 29 January 2016
Accepted: 31 July 2016
Published: 5 August 2016
In the ovary, sarcomatoid carcinoma has been reported only as mural nodules in epithelial malignant or borderline serous or mucinous cystic neoplasms, and in teratomas.
In this paper we report a rare case of a solid sarcomatoid carcinoma of the ovary, without accompanying component of giant cells, pleomorphic cells, or glandular and other epithelial structures.
This case report refers to a sarcomatoid carcinoma of the ovary in in a 57 year-old woman with abdominal pain.
Macroscopically, the neoplasm was a 15x10x5 cm ovarian mass that featured gray white solid fleshy areas, interspersed with areas of necrosis, hemorrhage and cystic spaces filled with thick fluid. The epithelial differentiation of the tumor was demonstrated by strong and diffuse reactivity to CAM5.2 and focal immunoreactivity to EMA. A diagnosis of malignant mesenchymal tumor was excluded due to negativity for desmin, smooth muscle actin, caldesmon, CD34, CD10, and myoglobin. Neural, neuroendocrine neoplasm, melanoma and Perivascular Epithelioid Cell Tumor (PEComa) were excluded because of negativity for S100, chromogranin, synaptophysin and HMB45.
Primary ovarian spindle cell carcinoma is a rare neoplasm, which must be considered in the differential diagnosis of solid ovarian mass with spindle cell appearance. This case adds to our knowledge of the biological behavior of these rare neoplasms. The distinction from true sarcomas and carcinosarcomas is important because of the more favorable prognosis of the spindle cell carcinomas. However their diagnosis necessitates a careful tissue sampling and immunohistochemical staining.
Sarcomatoid carcinoma is form of cancer, with controversial histogenesis, which shares histological, cytological, or molecular properties of both epithelial and mesenchymal differentiation.
Sarcomatoid carcinoma is referred to a pure spindle cell carcinoma which is distinguished from true sarcoma by its positive staining to cytokeratins. Multiple sections and immunohistochemical stains or ultrastructural study are required to support the diagnosis [1, 2].
Sarcomatoid carcinomas, known also as spindle cell (sarcomatoid) carcinomas, are rare malignancies and have been reported in many organs such as the breast [3, 5] urinary bladder [1, 2, 6], kidney  and lung [4, 8]. Ovarian anaplastic spindle cell carcinomas include three different subtypes, rhabdoid, spindled (sarcomatoid) and pleomorphic in epithelial malignant [9, 10], or serous and mucinous borderline [11, 12] cystic neoplasms, and in teratomas .
In this paper, we report a rare case of a solid sarcomatoid carcinoma of the ovary of spindle cell type.
A 53-year-old woman presented to our institution complaining of abdominal pain. Her personal history was unremarkable. Physical examination revealed a palpable mass lesion in the pelvic region. The results of laboratory investigations revealed increased CA125 levels (176.56 U/ml) (normal value: < 35 U/ml). Pelvic magnetic resonance imaging (MRI) scans suggested a malignant lesion located in the left ovary, showing the presence a large, complex mass with cystic solid components and necrotic areas. Hysterectomy with bilateral salpingo-oophorectomy, pelvic lymph node dissection and omentectomy were performed to establish stage of development of this neoplasm.
For accurate microscopic examination of solid areas, we used a sampling, suggested by other investigators for diagnosis of mucinous borderline and malignant tumors of the ovary . In line with this protocol, sampling of our tumor could be considered as optimal, because was examined one section per 1 cm of the maximum diameter .
In other smaller areas, the spindle neoplastic elements showed more abundant cytoplasm with epithelial-like appearance. The nuclei were atypical and vesicular, with evident nucleoli. Mitoses were frequent and sometimes atypical (Fig. 3b).
In numerous sections examined, no benign or malignant epithelial structures, nor histological elements, such as giant cells or pleomorphic cells were observed.
Immunohistochemical analysis was performed to establish true nature of tumor differentiating epithelial from mesenchymal, neuroendocrine neoplasms, melanoma and uterine Perivascular Epithelioid Cell Tumor (PEComa), sex cord tumors and (Gastrointestinal Stromal tumor) GIST.
Although a carcinomatous component was not recognized at microscopic examination, the epithelial nature of the tumor was established because of strong and diffuse reactivity to CAM 5.2 and focal positivity to EMA and cocktail of keratins.
Specimen of pelvic lymph node dissection did not reveal presence of metastases.
Abdominal ultrasound, chest X-ray, total computed tomography, or bone scan were unremarkable.
Therefore, the final diagnosis was primary ovarian sarcomatoid carcinoma of pT1a N0 M0 stage of development at the diagnosis.
The patient received six cycles of chemotherapy with carboplatin-Taxol.
After one year from diagnosis, surgery and chemotherapy, the patient is free of disease.
Histologically, ovarian carcinosarcomas are considered biphasic tumors with both carcinomatous (epithelial) and sarcomatous (stromal) elements. They can be sub-classified as “heterologous” or “homologous” based on the presence or absence of a stromal component containing mesenchymal tissues not normally found at the primary tumour site.
Anaplastic carcinoma of spindle cell type is an exceedingly rare ovarian neoplasm, with controversial histogenesis, with less than ten cases reported in the English medical literature. Three different types have been described, rhabdoid, spindled (sarcomatoid) and pleomorphic .
To the best of our knowledge, in the ovary, sarcomatoid carcinoma has only been reported as mural nodules in epithelial malignant [9, 10], or borderline [11, 12] cystic neoplasms, and in teratomas .
In our case, sarcomatoid carcinoma of the ovary was characterized only by a spindle cell component without epithelial structures.
In this case, the epithelial differentiation of the tumor was demonstrated by strong and diffuse reactivity to CAM 5.2 and focal positivity to EMA. A diagnosis of malignant mesenchymal tumor was excluded due to negativity for desmin, smooth muscle actin, caldesmon, CD34, CD10, and myoglobin. Neural, neuroendocrine neoplasm and melanoma and uterine Perivascular Epithelioid Cell Tumor (PEComa) were excluded because of negativity for S100, chromogranin, synaptophysin and HMB45.
Other neoplams such as sex cord tumors and (Gastrointestinal Stromal tumor) GIST were excluded due to negativity to negativity for alpha-Inhibin, and C-kit.
In many organs such as the kidney [16, 17], breast , and urinary bladder  sarcomatoid carcinomas are neoplasms, with poor prognosis. As a consequence of the relative rarity and diagnostic heterogeneity of these tumors, it has proven difficult to properly predict their behaviour and to determine optimal management.
Although it was first thought to carry an invariably unfavorable prognosis, recent data indicate that this does not apply to Ia tumors .
Our findings are consistent with the above mentioned data. In this case, at diagnosis, the neoplasm was located within the ovary (Stage: pT1a), without invasion of surrounding tissue and lymph nodes metastases and was treated with combined chemotherapy treatment with carboplatin and taxol. After one year from diagnosis, the patient is free of disease and this might suggest that its aggressiveness is lower than anaplastic spindle cell carcinoma, present in other organs.
The sarcomas are characterized by presence of malignant mesenchymal elements and these include stromal cell sarcomas, fibrosarcomas, leiomyosarcomas, neurofibrosarcomas, rhabdomyosarcomas, chondrosarcomas, angiosarcomas, and liposarcomas . Carcinosarcoma is a mixed Müllerian (MMT), and is characterized by the presence of both carcinomatous and sarcomatous component. Ovarian MMTs can be classified as homologous or heterologous. In the homologous subtype can be observed tissue normally present in the ovary. On the contrary, in the heterologous subtype the neoplasm shows tissues that is not normally present in the ovary .
Extensive sampling is mandatory for the exclusion of MMTs, which carry a more ominous prognosis .
Our case refers to a spindle cell carcinoma of the ovary which appears as a solid mass. For diagnosis in this case cystic spaces were entirely submitted for histological evaluation and solid areas were examined using protocol used by other Author for diagnosis of mucinous borderline and malignant tumors of the ovary .
Furthermore, in our opinion, this case, is in line with other cases of sarcomatoid carcinomas observed in different organs.
This is the first case report of sarcomatoid (spindle cell carcinoma) of the ovary, which appears as a solid mass. Moreover, this case demonstrates that findings of malignant spindle cell proliferation does not imply that this entity is a sarcoma or malignant Mixed Müllerian Tumor (MMT). Additionally, careful tissue sampling and immunohistochemical analysis to distinguish between these different entities is mandatory.
GIST, gastro-intestinal stromal tumor; MMT, mixed Müllerian tumor; MRI, magnetic resonance imaging; PEComa, Perivascular Epithelioid Cell Tumor
All authors have contributed to this paper and consent the publication. The authors would like to thank Alexander Gillan for his help in english translation, Mrs Gabriella Becchi and Katiuscia Barbieri for technical assistance.
No istitutional funding, but personal of corresponding Author G Giordano.
GG and ES drafted the manuscript. GG provided imaging description and figures. ES assisted with literature collection and diagnosis, RB provided clinical data. All authors have read and approved the final manuscript.
GG (MD, PhD): Assistant professor of Department of Biomedical, Biotechnological and Translational Sciences, Pathological Anatomy and Histology Unit, Faculty of Medicine, University of Parma, Italy.
RB (MD, PhD): Assistant professor of Department of Obstetric and Gynecologic Sciences and Neonatology, Parma University, Italy.
ES (MD, PhD): Professor, Department of Biomedical, Biotechnological and Translational Sciences, Pathological Anatomy and Histology Unit, Faculty of Medicine, University of Parma, Italy.
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patient's for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Lopez-Beltran A, Pacelli A, Rothenberg HJ, Wollan PC, Zincke H, Blute ML, et al. Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases. J Urol. 1998;159(5):1497–503.View ArticlePubMedGoogle Scholar
- Cheng L, Zhang S, Alexander R, Maclennan GT, Hodges KB, Harrison BT, et al. Sarcomatoid carcinoma of the urinary bladder: the final common pathway of urothelial carcinoma dedifferentiation. Am J Surg Pathol. 2011;35(5):e34–46.View ArticlePubMedGoogle Scholar
- Foschini MP, Dina RE, Eusebi V. Sarcomatoid neoplasms of the breast: proposed definitions for biphasic and monophasic sarcomatoid mammary carcinomas. Semin Diagn Pathol. 1993;10(2):128–36.PubMedGoogle Scholar
- Nappi O, Glasner SD, Swanson PE, Wick MR. Biphasic and monophasic sarcomatoid carcinomas of the lung. A reappraisal of ‘carcinosarcomas’ and “spindle-cell carcinomas”. Am J Clin Pathol. 1994;102(3):331–40.View ArticlePubMedGoogle Scholar
- Carter MR, Hornick JL, Lester S, Fletcher CD. Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases. Am J Surg Pathol. 2006;30(3):300–9.View ArticlePubMedGoogle Scholar
- Torenbeck R, Blomjous CEM, Bruin PC, Newling DWW, Meijer CLJM. Sarcomatoid cancer of the urinary bladder. Clinicopathological analysis of 18 cases with immunohistochemical and electron microscopic findings. Am J Surg Pathol. 1994;18:241–9.View ArticleGoogle Scholar
- Molina AM, Tickoo SK, Ishill N, Trinos MJ, Schwartz LH, Patil S, et al. Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease. Am J Clin Oncol. 2011;34(5):454–9.View ArticlePubMedPubMed CentralGoogle Scholar
- Terada T. Spindle cell carcinoma of the lung: Frequency, clinical features, and immunohistochemical studies of three cases. Respi Med CME. 2010;3(4):241–5.View ArticleGoogle Scholar
- Czernobilsky B, Dgani R. Roth L Ovarian mucinous cistoadenocarcinoma with mural nodule of carcinomatous derivation. Cancer. 1983;51:141–8.View ArticlePubMedGoogle Scholar
- Hillesheim PB, Farghaly H. Anaplastic spindle cell carcinoma, arising in a background of an ovarian mucinous cystic tumor: a case report with clinical follow up, review of the literature. Int J Clin Exp Pathol. 2010;3(8):808–11.PubMedPubMed CentralGoogle Scholar
- Dutton PM, Beattie G, Al-Nafussi A. Sarcomatoid carcinoma arising within a serous borderline ovarian tumour: a case report and practical approach to differential diagnosis. Histopathology. 2008;52(2):233–8.PubMedGoogle Scholar
- Ghosh P, Saha K, Bhowmik S. Sarcoma-like mural nodule in a borderline mucinous tumor of the ovary: A rare entity. J Midlife Health. 2014;5(4):192–4. doi:10.4103/0976-7800.145168.PubMedPubMed CentralGoogle Scholar
- Czernobilsky B, Rotenstreich L, Lancet M. Ovarian dermoid with squamous carcinoma-pseudosarcoma. Arch. 1972;93:141–4.Google Scholar
- Guerrieri C, Högberg T, Wingren S, Fristedt S, Simonsen E, Boeryd B. Mucinous borderline and malignant tumors of the ovary. A clinicopathologic and DNA ploidy study of 92 cases. Cancer. 1994;74:2329–40.View ArticlePubMedGoogle Scholar
- Mano MS, Rosa DD, Azambuja E, Ismael G, Braga S, D’Hondt V, et al. Current management of ovarian carcinosarcoma. Int J Gynecol Cancer. 2007;17:316–24.View ArticlePubMedGoogle Scholar
- Peralta-Venturina M, Moch H, Amin M, Tamboli P, Hailemariam S, Mihatsch M, et al. Sarcomatoid differentiation in renal cell carcinoma: A study of 101 cases. Am J Surg Pathol. 2001;25:275–84.View ArticlePubMedGoogle Scholar
- Cheville JC, Lohse CM, Zincke H, Weaver AL, Leibovich BC, Frank I, et al. Sarcomatoid renal cell carcinoma: An examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol. 2004;28:435–41.View ArticlePubMedGoogle Scholar
- Sahin A, Benda JA. An immunohistochemical study of primary ovarian sarcoma. An evaluation of nine tumors. Int J Gynecol Pathol. 1988;7(3):268–79.View ArticlePubMedGoogle Scholar
- Menon S, Deodhar K, Rekhi B, Dhake R, Gupta S, Ghosh J, et al. Clinico-pathological spectrum of primary ovarian malignant mixed mullerian tumors (OMMMT) from a tertiary cancer institute: A series of 27 cases. Indian J Pathol Microbiol. 2013;56(4):365–71.View ArticlePubMedGoogle Scholar